FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,824,000 | +126.6% | 48,408 | +2.2% | 0.00% | +100.0% |
| Q4 2020 | $805,000 | +323.7% | 47,346 | +17.2% | 0.00% | – |
| Q3 2020 | $190,000 | -22.8% | 40,381 | 0.0% | 0.00% | – |
| Q2 2020 | $246,000 | +127.8% | 40,381 | -15.4% | 0.00% | – |
| Q1 2020 | $108,000 | -56.3% | 47,722 | -11.2% | 0.00% | – |
| Q4 2019 | $247,000 | +18.8% | 53,716 | 0.0% | 0.00% | – |
| Q3 2019 | $208,000 | -32.9% | 53,716 | +4.6% | 0.00% | -100.0% |
| Q2 2019 | $310,000 | -54.9% | 51,348 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $688,000 | +41.0% | 51,348 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $488,000 | -31.3% | 52,526 | +2.9% | 0.00% | 0.0% |
| Q3 2018 | $710,000 | -11.6% | 51,023 | +0.5% | 0.00% | -50.0% |
| Q2 2018 | $803,000 | -6.7% | 50,792 | +1.4% | 0.00% | 0.0% |
| Q1 2018 | $861,000 | -8.3% | 50,093 | +16.9% | 0.00% | 0.0% |
| Q4 2017 | $939,000 | -47.4% | 42,855 | -1.9% | 0.00% | -50.0% |
| Q3 2017 | $1,786,000 | +23.1% | 43,664 | -9.4% | 0.00% | +33.3% |
| Q2 2017 | $1,451,000 | -24.5% | 48,175 | -9.4% | 0.00% | -25.0% |
| Q1 2017 | $1,922,000 | -31.1% | 53,175 | -4.5% | 0.00% | -33.3% |
| Q4 2016 | $2,790,000 | -7.0% | 55,675 | -2.6% | 0.01% | 0.0% |
| Q3 2016 | $3,001,000 | +28.3% | 57,175 | +1.1% | 0.01% | +20.0% |
| Q2 2016 | $2,339,000 | +19.8% | 56,575 | +17.8% | 0.01% | +25.0% |
| Q1 2016 | $1,952,000 | +11.9% | 48,032 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $1,744,000 | +189.2% | 42,025 | +7.3% | 0.00% | +100.0% |
| Q3 2015 | $603,000 | -38.2% | 39,183 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $976,000 | +14.8% | 39,283 | +5.6% | 0.00% | 0.0% |
| Q1 2015 | $850,000 | -1.0% | 37,217 | +17.0% | 0.00% | 0.0% |
| Q4 2014 | $859,000 | +130.9% | 31,817 | +0.4% | 0.00% | +100.0% |
| Q3 2014 | $372,000 | -24.1% | 31,681 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $490,000 | +102.5% | 31,500 | +156.1% | 0.00% | 0.0% |
| Q1 2014 | $242,000 | +41.5% | 12,300 | +20.6% | 0.00% | – |
| Q4 2013 | $171,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|